April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Evaluation of Retinal Toxicity by ERG Before and After Pars Plana Vitrectomy in ILM Peeling Assisted by Brilliant Blue G Staining at a Concentration of 1 mg/ml, 6 Months of Follow Up
Author Affiliations & Notes
  • Ana I. Ortiz
    Retina- Col San Lucas Coyoacan, APEC, Mexico City, Mexico
  • Miriam Jessica J. Lopez-Miranda
    Ophthalmology, Assoc Para Evitar la Ceguera en Mex, Toluca, Mexico
  • Valentina Franco-Cardenas
    Ophthalmology, Assoc Para Evitar la Ceguera en Mex, Toluca, Mexico
  • Jose Luis Guerrero-Naranjo
    Ophthalmology, Assoc Para Evitar la Ceguera en Mex, Toluca, Mexico
  • Juan Jimenez-Sierra
    Asoc Para Evitar la Ceguera en Mexico, Mexico City, Mexico
  • Hugo Quiroz-Mercado
    Asoc Para Evitar la Ceguera en Mexico, Mexico City, Colorado
  • Virgilio Morales-Canton
    Retina Department, Asociacion para Evitar la Ceguera, Mexico, Mexico
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 6116. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ana I. Ortiz, Miriam Jessica J. Lopez-Miranda, Valentina Franco-Cardenas, Jose Luis Guerrero-Naranjo, Juan Jimenez-Sierra, Hugo Quiroz-Mercado, Virgilio Morales-Canton; Evaluation of Retinal Toxicity by ERG Before and After Pars Plana Vitrectomy in ILM Peeling Assisted by Brilliant Blue G Staining at a Concentration of 1 mg/ml, 6 Months of Follow Up. Invest. Ophthalmol. Vis. Sci. 2011;52(14):6116.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate in vivo retinal toxicity after surgical application of brilliant blue G using a 1 mg/ml concentration with standard electroretinogram (ERG).

Methods: : Fourteen patients underwent phacoemulsification with IOL implantation and pars plana vitrectomy with peeling of the internal limiting membrane (ILM) assisted with 1 mg/ml concentration of brilliant blue G. Gas tamponade with SF6 was used in all cases. Best corrected visual acuity (BCVA) measurement and ERG were performed prior to surgery, one and six months afterwards. Macular hole architecture and closure were evaluated clinically and by spectral domain optical coherence tomography (SD-OCT).

Results: : 10 female and 4 male were enrolled in the study with a mean age of 66.84 ±5.88 years. A sufficient staining of the ILM was seen in all cases and peeling was successfully achieved. BCVA improved one line. Clinical observation showed closure of all macular holes and was confirmed by SD-OCT. B-wave amplitude on maximal ERG was 335.43±116.31µV preoperatively and 330.03 ±88.27 µV at 3 months and 309.52 ±12.20 µV at 6 months postoperatively (p=0.56). Implicit time on maximal ERG was 68.18 ±35.72 msec preoperatively and 50.53 ±3.17 msec at 3 months and 50.6 ±5.22 msec at 6 months postoperatively (p=0.77).

Conclusions: : Using a concentration of 1 mg/ml of brilliant blue G in the treatment of macular hole for staining the ILM seems to have no retinal toxicity detected by ERG at 6 months of follow up; and has the same visual outcome as previous concentrations reported. More patients and further studies are needed.

Keywords: drug toxicity/drug effects • electrophysiology: clinical • macular holes 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×